Detalhe da pesquisa
1.
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.
Radiology
; 307(1): e220762, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511804
2.
Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study.
Lancet Oncol
; 23(3): 428-438, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240084
3.
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
Radiology
; 305(3): 623-630, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916679
4.
Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells.
J Urol
; 203(1): 73-82, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31389764
5.
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Radiology
; 291(2): 391-397, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30938627
6.
Targeted biopsy of the prostate: does this result in improvement in detection of high-grade cancer or the occurrence of the Will Rogers phenomenon?
BJU Int
; 124(4): 643-648, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31081983
7.
Multiparametric ultrasound in the diagnosis of prostate cancer.
Curr Opin Urol
; 26(1): 114-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26555694
9.
Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting.
BJU Int
; 115(5): 728-35, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041307
10.
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions.
Eur Urol Focus
; 9(5): 781-787, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031096
11.
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre.
Eur J Radiol
; 162: 110796, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003197
12.
Re: Limitations of Elastography Based Prostate Biopsy: J. Schiffmann, M. Grindei, Z. Tian, D.-J. Yassin, T. Steinwender, S.-R. Leyh-Bannurah, M. Randazzo, M. Kwiatkowski, P. I. Karakiewicz, P. Hammerer and L. Manka J Urol 2016;195:1731-1736.
J Urol
; 197(1): 263-264, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27765703
13.
Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models.
Diagnostics (Basel)
; 12(7)2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35885536
14.
Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer.
BMJ Open
; 12(4): e059847, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396316
15.
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.
Front Oncol
; 12: 1060864, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727071
16.
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing.
BJUI Compass
; 3(6): 458-465, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36267207
17.
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial.
Cancers (Basel)
; 13(8)2021 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33924255
18.
The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy.
Eur Urol Focus
; 7(5): 1027-1034, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046412
19.
Prostate cancer biology & genomics.
Transl Androl Urol
; 9(3): 1481-1491, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676435
20.
Can transrectal prostate ultrasound compete with multiparametric MRI in the detection of clinically significant prostate cancer?
Transl Androl Urol
; 9(3): 1492-1500, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676436